Vivos Therapeutics Raises $4.64M Through Warrant Exercise Amidst Financial Challenges

Vivos Therapeutics (VVOS) has adjusted the exercise price of certain outstanding warrants, potentially raising $4.64 million. The company is issuing new unregistered warrants in a private placement, with varying expiration terms. Vivos Therapeutics operates in the healthcare sector, focusing on non-invasive solutions for sleep-disordered breathing. The transaction is expected to finalize around January 20, pending standard closing conditions.